This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Adam Sichol

Adam is Co-Founder and CEO of Longfellow Real Estate Partners and has been investing in life science real estate since 2000. He is responsible for directing Longfellow’s overall strategic direction and its continued portfolio expansion.
Since co-founding Longfellow in 2009, he has overseen the growth of the company through the execution of value-add and development projects for institutional and commercial tenants.
Under Adam’s leadership, Longfellow has invested more than $3 billion on behalf of institutional investors. In addition, Adam has played an active role in the leasing activities of the firm, including work with companies across a broad range of the life science ecosystem from newly-formed VC portfolio companies to major pharmaceutical companies and academic institutions. Adam is a member of Longfellow’s investment committee.
Prior to forming Longfellow, Adam started his life science real estate career at Lyme Properties, one of the laboratory pioneers that led the development of Kendall Square in Cambridge, MA into a global life science hub. He has also held positions with Higgins Development Partners and Jones Lang LaSalle.
Adam received his MBA from the Tuck School of Business at Dartmouth and an AB from Hamilton College where he was a member of the men’s varsity golf team. Adam is a member of ULI and NAIOP and speaks at various industry events related to science and technology real estate projects.